3.
治疗前后胰岛素抵抗及非胰岛素抵抗患者BMI、WHR及HOMA-IR的变化
BMI, WHR and HOMA-IR in patients with IR and Non-IR before and during treatment (Mean±SD)
| Parameter | Baseline | 3 months | 6 months |
| There was a significant difference before and during treatment, *P < 0.05. | |||
| BMI (kg/m2) | |||
| IR | |||
| Group A | 22.91±4.24 | 22.31±3.91* | 22.37±3.62* |
| Group B | 23.14±3.27 | 22.77±2.97* | 22.58±2.80* |
| Non-IR | |||
| Group A | 20.48±1.53 | 20.75±1.36* | 20.80±1.40* |
| Group B | 20.46±1.03 | 20.77±1.20* | 20.85±1.04* |
| WHR | |||
| IR | |||
| Group A | 0.84±0.09 | 0.82±0.07* | 0.82±0.08* |
| Group B | 0.83±0.06 | 0.82±0.05* | 0.82±0.05* |
| Non-IR | |||
| Group A | 0.79±0.04 | 0.80±0.04 | 0.81±0.05 |
| Group B | 0.78±0.04 | 0.80±0.03* | 0.81±0.03* |
| HOMA-IR | |||
| IR | |||
| Group A | 4.05±3.06 | 3.88±2.30 | 3.75±2.27 |
| Group B | 3.86±3.01 | 3.67±2.49 | 3.38±1.67 |
| Non-IR | |||
| Group A | 1.88±0.96 | 2.25±0.80* | 2.27±1.01* |
| Group B | 1.71±0.49 | 2.16±1.34 | 2.29±0.72* |